Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma; a Randomized Controlled Trial

NCT05135832 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT05135832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma; a Randomized Controlled Trial
Lead sponsor
Herlev and Gentofte Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 13, 2021
Completion date
December 1, 2022
Enrollment
174 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced renal cell carcinoma, kidney cancer, kidney neoplasm, metastatic renal cell carcinoma, urologic cancer, urologic neoplasms